[1]
S. Merchant, PhD, D. Provenzano, MD, S. Mody, PharmD, MBA, K. F. Ho, PhD, and M. Etropolski, MD, “Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: Pooled analysis of randomized studies”, J of Opioid Management, vol. 9, no. 1, pp. 51–61, Jan. 2013.